SoftBank Group Corp. 13D and 13G filings for Neumora Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:30 pm Sale | 2024-09-30 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA | SoftBank Group Corp. | 7,546,916 4.700% | -100,000 (-1.31%) | Filing |
| 2024-02-13 5:00 pm Purchase | 2023-12-31 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA | SoftBank Group Corp. | 7,646,916 5.000% | 7,646,916 (New Position) | Filing |